Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00612066 · MORE INFO

Limitations, agreements, and source contact

Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease) · Source last updated 2020-08-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Recruitment was a major limitation. Patients were available but were not interested in the study due to possible side effects of the study drug.
point Of Contact
email
aheaney@mednet.ucla.edu
organization
University of California, Los Angeles
phone
310 267 4980
title
Anthony Heaney, M.D. Ph.D
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
limitations And Caveats
description
Recruitment was a major limitation. Patients were available but were not interested in the study due to possible side effects of the study drug.
point Of Contact
email
aheaney@mednet.ucla.edu
organization
University of California, Los Angeles
phone
310 267 4980
title
Anthony Heaney, M.D. Ph.D

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice